This webcast originally aired as a live webinar sponsored
by AACC on June 11, 2013. During this program, Dr. Robert Middleburg discusses
the process his lab uses to determine when and when not to develop a test for
new structurally unique substances like synthetic cannabinoids, advances
occurring in toxicological testing that can help labs keep up with evolving
trends in drug abuse, the value of toxicological testing in diagnosing and
treating poisoned patients, and strategies labs can use to meet the clinical
needs for toxicological testing in their organizations.